November 22nd 2024
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Drospirenone/Ethinyl Estradiol (Yasmin®): New Oral Contraceptive Promises Improved Tolerance
July 29th 2011With a number of clinical studies now completed, the launch of drospirenone/ethinyl estradiol (Yasmin®) in the United States and Europe is expected in the near future. An international panel of physicians involved with the development of drospirenone/ethinyl estradiol recently described the potential benefits of the new oral contraceptive (OC) to clinicians attending an industry-sponsored symposium held during the XVI FIGO World Congress of Gynecology and Obstetrics.
Read More
Tailoring HRT to Your Patients: An Expert Roundtable Discussion on the Issue
The topic of hormone replacement therapy (HRT) continues to emerge as a central theme that we, as clinicians to female patients, address every day. We recognize that the public is much more aware of and interested in HRT now than was the case a decade ago.
Read More
An Overlooked Connection: Serotonergic Mediation of Estrogen-related Physiology and Pathology
July 28th 2011In humans, serotonin has typically been investigated as a neurotransmitter. However, serotonin also functions as a hormone across animal phyla, including those lacking an organized central nervous system.
Read More
OCs for Perimenopausal Women: Who Might Benefit from the Pill?
July 28th 2011Healthy, nonsmoking perimenopausal women can derive a host of benefits from using oral contraceptives (OCs). Along with providing effective contraception, OCs can regulate their menstrual cycles, reduce hot flashes, and protect against two gynecologic cancers.
Read More
Implantable Devices Should Be Offered as First-Line Contraception
July 24th 2011The most effective forms of reversible contraception available to date are long-acting reversible contraceptives (LARCs), which include intrauterine devices (IUDs) and implants.1 According to The American College of Obstetricians and Gynecologists (The College), LARCs are safe for almost all women of reproductive age, including nursing mothers, adolescents, and women who have not yet had a child, and The College recommends them as first-line contraceptive methods.
Read More
Placental Localization by Transperineal Sonography in Antepartum Hemorrhage
July 22nd 2011Transperineal and transabdominal sonography were done for 180 patients attending Benha University Hospitals at 28-40 weeks gestational age with an antepartum hemorrhage in the period between July, 1995 and October, 1996.
Read More
This article examines issues surrounding noncompliance, and offers advice regarding effective patient counseling. It also highlights the importance of OC packaging: Market research studies suggest that more discreet and more convenient styles of packaging may promote consistent use.
Read More
Health Benefits of The Birth Control Pill
July 13th 2011The introduction of the Pill in the 1960’s was probably one of the most liberating events in the history of women. Providing a safe and effective method of contraception, which women could easily control themselves, it enabled women to impact society like never before. Since its introduction, it has probably become one of the most widely studied medications ever.
Read More
Contraceptive Options for Adolescents
July 13th 2011Contraceptive behavior is related to changing age structure, and change in upper age limits for OCs use. However, there are unpredictable factors affecting contraceptive use such as the publicity regarding OCs and breast cancer and concern about sexually transmitted diseases (STDs) including human immunodeficiency virus infection as well as abortion legislation.
Read More
Ultrasound Informal Case Multiload IUD
July 13th 2011(fig. 1) I was so astonished by the 3D image that I wanted to share with you. Look at the shape of the copper coil, it's amazing. Submitted by Daniel Margulies, Argentina. (fig. 2) "This is my best 3D Multiplanar Reconstruction of Multiload IUD."Image provided by:Mrio Libardi, M.D.Multimagem Ultra-sonografiaBotucatu, Sao PauloBrasil (fig. 3) Image provided courtesy of Antwoord van dr. R.J.C.M. Beerthuizen, directeur Stichting Anticonceptie Nederland, Winterswijk (fig. 4) Image provided by:Mrio Libardi, M.D.Multimagem Ultra-sonografiaBotucatu, Sao PauloBrasilFor more images and information about IUDs, please click here CommentsMy gut tells me that this may be an image artifact that is unique to 3D sonography. If any of you heard the lecture on 3D artifacts in Buenos Aries by Dr. Andrew Hull... he was clear that 3D introduces new categories of image artifacts and a new "twist" on old familiar artifacts. You can see the interview of Dr. Hull at:http://www.obgyn.net/displaytranscript.asp?page=/avtranscripts/dubose_hull This is probably not useful pathologically, but as a phenomenon of 3D sonography it may be important educationally to us end users. I would like to post it and see more discussion. Peace, Terry J. DuBose, M.S., RDMS Assistant Professor & Director, Diagnostic Medical Sonography Program CHRP, University of Arkansas for Medical Sciences Little Rock, Arkansas, USA 501-686-6510http://www.io.com/~dubose/http://www.uams.edu/CHRP/dmshome.htmhttp://www.obgyn.net/us/panel/panel.htm
Read More
The contraceptive patch (Ortho Evra™ transdermal system) is a weekly hormonal birth control method that received Food and Drug Administration approval in November 2001. The product is an adhesive patch, similar to a large Band Aid®, that a woman places onto her skin to prevent pregnancy. The patch contains hormones that are released through the skin and into the bloodstream.
Read More
Effects of estrogen plus progestin on health-related quality of life
July 13th 2011The purpose of the Women’s Health Initiative hormone program was to study the health benefits and risks of hormones for postmenopausal women. In July 2002, we asked women in the estrogen plus progestin part of the program to stop taking their study pills.
Read More
Emergency Contraception Prevents Fertilization, not Implantation, Studies Show
July 13th 2011Recent research by members of the Population Council's International Committee for Contraception Research (ICCR) and other scientists shows that emergency contraceptive pills appear to work by interfering with ovulation, thus preventing fertilization of the egg.
Read More
New overview adds more evidence for safety of third generation oral contraceptives
July 13th 2011A new overview of studies of the Pill and the risk of heart attack, published today (Friday 30 August) in Europe's leading reproductive medicine journal, Human Reproduction,* provides a reassuring picture of the safety of the third generation Pill.
Read More